358 related articles for article (PubMed ID: 18701097)
1. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
Park JK; Clark R; Session DR
Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
[TBL] [Abstract][Full Text] [Related]
2. A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in a pre- and postovulatory mouse follicle culture model.
Foster R; Segers I; Smart D; Adriaenssens T; Smitz J; Arce JC; Princivalle M
Fertil Steril; 2010 Mar; 93(5):1464-76. PubMed ID: 19362302
[TBL] [Abstract][Full Text] [Related]
3. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
[TBL] [Abstract][Full Text] [Related]
4. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
[TBL] [Abstract][Full Text] [Related]
5. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
Grøndahl ML; Borup R; Lee YB; Myrhøj V; Meinertz H; Sørensen S
Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
[TBL] [Abstract][Full Text] [Related]
6. The importance of the FSH/LH ratio in ovarian stimulation therapy regime for in vitro fertilization.
Bhat AM; Feichtinger W; Kemeter P
Acta Eur Fertil; 1984; 15(6):449-53. PubMed ID: 6443053
[TBL] [Abstract][Full Text] [Related]
7. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
[TBL] [Abstract][Full Text] [Related]
8. Viable pregnancy in a woman with premature ovarian failure treated with gonadotropin suppression and human menopausal gonadotropin stimulation. A case report.
Check JH; Nowroozi K; Nazari A
J Reprod Med; 1991 Mar; 36(3):195-7. PubMed ID: 1903165
[TBL] [Abstract][Full Text] [Related]
9. GnRH antagonists in poor responders.
Kolibianakis E; Albano C; Zikopoulos K; Kahn JA; Van Steirteghem A; Devroey P
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1216-7. PubMed ID: 15548159
[No Abstract] [Full Text] [Related]
10. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
Gynecol Endocrinol; 2010 Oct; 26(10):733-5. PubMed ID: 20500109
[TBL] [Abstract][Full Text] [Related]
11. Relationships between the characteristics of endogenous luteinizing hormone surge and the degree of ovarian hyperstimulation during superovulation induction in women.
Messinis IE; Templeton A; Baird DT
Clin Endocrinol (Oxf); 1986 Oct; 25(4):393-400. PubMed ID: 3113775
[TBL] [Abstract][Full Text] [Related]
12. New advances in ovulation induction.
Kafy S; Tulandi T
Curr Opin Obstet Gynecol; 2007 Jun; 19(3):248-52. PubMed ID: 17495641
[TBL] [Abstract][Full Text] [Related]
13. Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin.
Al-Inany H; Aboulghar MA; Mansour RT; Serour GI
Gynecol Endocrinol; 2005 Mar; 20(3):161-9. PubMed ID: 16019356
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S
Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
[TBL] [Abstract][Full Text] [Related]
15. Pure follicle stimulating hormone does not enhance follicular recruitment in clomiphene citrate/gonadotropin combinations.
Quigley MM; Collins RL; Blankstein J
Fertil Steril; 1988 Oct; 50(4):562-6. PubMed ID: 3139463
[TBL] [Abstract][Full Text] [Related]
16. The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program.
Chang MY; Chiang CH; Chiu TH; Hsieh TT; Soong YK
J Assist Reprod Genet; 1998 Jan; 15(1):12-7. PubMed ID: 9493060
[TBL] [Abstract][Full Text] [Related]
17. Clomiphene citrate-induced follicular development in the presence of an ovarian ectopic pregnancy.
Bayrak A; Fogle RH; Paulson RJ
Fertil Steril; 2008 Feb; 89(2):456.e1-2. PubMed ID: 17517395
[TBL] [Abstract][Full Text] [Related]
18. Follicular fluid cyclic nucleotides, prostaglandin E2, leukotriene B4, oestradiol, progesterone and luteinizing hormone in women stimulated by clomiphene and gonadotropins.
Heinonen PK; Punnonen R; Teisala K; Ashorn R; Kujansuu E; Seppälä E; Mörsky P; Metsä-Ketelä T
Acta Eur Fertil; 1988; 19(6):325-8. PubMed ID: 2855188
[TBL] [Abstract][Full Text] [Related]
19. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study.
Platteau P; Andersen AN; Balen A; Devroey P; Sørensen P; Helmgaard L; Arce JC;
Hum Reprod; 2006 Jul; 21(7):1798-804. PubMed ID: 16571641
[TBL] [Abstract][Full Text] [Related]
20. Does optimal follicular size in IUI cycles vary between clomiphene citrate and gonadotrophins treatments?
Shalom-Paz E; Marzal A; Wiser A; Hyman J; Tulandi T
Gynecol Endocrinol; 2014 Feb; 30(2):107-10. PubMed ID: 24266698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
